Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells

被引:67
作者
Siafakas, CG
Anatolitou, F
Fusunyan, RD
Walker, WA
Sanderson, IR
机构
[1] Massachusetts Gen Hosp, Dev Gastroenterol Lab, Harvard Clin Nutr Res Ctr, Combined Program Pediat Gastroenterol & Nutr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Aghia Sophia Childrens Hosp, Neonatal Unit 2D, Athens 11527, Greece
[4] Univ London Queen Mary & Westfield Coll, Dept Paediat Gastroenterol, St Bartholomews & Royal London Sch Med & Dent, London EC1A 7BE, England
关键词
D O I
10.1203/00006450-199905010-00007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
VEGF (vascular endothelial growth factor) is a multifunctional cytokine active on blood vessel cells. The present study measured VEGF in the aqueous phase of human milk and examined how the concentration varied with gestational age and the duration of lactation after birth, We hypothesized that VEGF-specific receptors were present on the apical surface of intestinal epithelial cells. The concentration of monomeric VEGF (containing 165 residues) measured by ELISA in the breast milk was 2 orders of magnitude greater than that measured in the serum of normal adults. The VEGF165 concentration in the first week of lactation was greater in the breast milk of mothers of full-term than in preterm babies (p < 0.05). The concentration in the breast milk of mothers of full-term infants decreased (p < 0.01) after the first week of lactation. Scatchard analysis of radioligand-receptor binding showed the presence of specific receptors for I-125-VEGF165 on the surface of Caco-2, an intestinal epithelial cell line, with a k(d) of 2.85 to 4 nM. Reverse transcriptase PCR of Caco-2 cell RNA showed mRNA for the VEGF receptor flt-1. in conclusion, VEGF is present in high concentrations in breast milk and binds to specific receptors on cells derived from intestinal epithelium.
引用
收藏
页码:652 / 657
页数:6
相关论文
共 23 条
[1]   Serum vascular endothelial growth factor levels in various liver diseases [J].
Akiyoshi, F ;
Sata, M ;
Suzuki, H ;
Uchimura, Y ;
Mitsuyama, K ;
Matsuo, K ;
Tanikawa, K .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (01) :41-45
[2]  
BROWN LF, 1993, CANCER RES, V53, P4727
[3]  
BROWN LF, 1997, EXS, V79, P233
[4]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[5]   VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION [J].
CONNOLLY, DT .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :219-223
[6]   VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR EXPRESSION IN THE RAT UTERUS - RAPID STIMULATION BY ESTROGEN CORRELATES WITH ESTROGEN-INDUCED INCREASES IN UTERINE CAPILLARY-PERMEABILITY AND GROWTH [J].
CULLINANBOVE, K ;
KOOS, RD .
ENDOCRINOLOGY, 1993, 133 (02) :829-837
[7]   THE IMMUNE-SYSTEM OF HUMAN-MILK - ANTIMICROBIAL, ANTIINFLAMMATORY AND IMMUNOMODULATING PROPERTIES [J].
GOLDMAN, AS .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (08) :664-671
[8]   VASCULAR-PERMEABILITY FACTOR, AN ENDOTHELIAL-CELL MITOGEN RELATED TO PDGF [J].
KECK, PJ ;
HAUSER, SD ;
KRIVI, G ;
SANZO, K ;
WARREN, T ;
FEDER, J ;
CONNOLLY, DT .
SCIENCE, 1989, 246 (4935) :1309-1312
[9]   BREAST-MILK AND NEONATAL NECROTIZING ENTEROCOLITIS [J].
LUCAS, A ;
COLE, TJ .
LANCET, 1990, 336 (8730) :1519-1523
[10]  
MAGNUSSON KE, 1982, IMMUNOLOGY, V45, P239